IL12 Signaling Deficiency is a Novel Cause of the Autoimmune Lymphoproliferative Syndrome

被引：0

作者：

Nabhani, S. ^{[1
]}

Ginzel, S. ^{[1
]}

Hagit, M. ^{[2
]}

Revel-Vilk, S. ^{[3
]}

Harlev, D. ^{[2
]}

Fleckenstein, B. ^{[4
]}

Thiele, R. ^{[5
]}

Laws, H. J. ^{[1
]}

Borkhardt, A. ^{[1
]}

Stepensky, P. ^{[3
]}

Fischer, U. ^{[1
]}

机构：

[1] Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany

[2] Shaare Zedek Med Ctr, Pediat Hematol Unit, Jerusalem, Israel

[3] Hadassah Hebrew Univ Med Ctr, Shaare Zedek Med Ctr, Jerusalem, Israel

[4] Univ Erlangen Nurnberg, Dept Clin & Mol Virol, D-91054 Erlangen, Germany

[5] Bonn Rhein Sieg Univ Appl Sci, Dept Comp Sci, St Augustin, Germany

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

ESID-0410

引用

页码：S164 / S165

页数：2

共 50 条

[21] Human IL12RB1 expression is allele-biased and produces a novel IL12 response regulator
Reeme, Allison E.
Claeys, Tiffany A.
Aggarwal, Praful
Turner, Amy J.
Routes, John M.
Broeckel, Ulrich
Robinson, Richard T.
GENES AND IMMUNITY, 2019, 20 (03) : 181 - 197
[22] A case of autoimmune lymphoproliferative syndrome with a novel de novo FAS variant
Ozcelik, Firat
Aslan, Kubra
Gok, Veysel
Ari, Mucahit Bilgehan
Ozcan, Alper
Eken, Ahmet
Unal, Ekrem
Ozkul, Yusuf
Dundar, Munis
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (04) : 301 - 309
[23] A NOVEL LYMPHOPROLIFERATIVE AUTOIMMUNE SYNDROME RESEMBLING MURINE LPR/GLD DISEASE
SNELLER, MC
STRAUS, SE
JAFFE, ES
JAFFE, JS
FLEISHER, TA
STETLERSTEVENSON, M
STROBER, W
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02): : 334 - 341
[24] Novel genetic defect in autoimmune lymphoproliferative syndrome-like disease
Mao, H.
Zhao, X.
Fischer, A.
Lau, Y. -L
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1232 - 1232
[25] Elevated IL-10 mRNA and protein in patients with autoimmune lymphoproliferative syndrome (ALPS)
Yao, X
Lopatin, U
Teruya-Feldstein, J
Dale, JK
Cheung, A
Setsuda, J
Quintanilla-Martinez, L
Raffeld, M
Straus, SE
Jaffe, ES
LABORATORY INVESTIGATION, 1999, 79 (01) : 149A - 149A
[26] IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome
Niss, Omar
Sholl, Allyson
Bleesing, Jack J.
Hildeman, David A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (03) : 762 - 770
[27] Lentiviral delivery of novel fusion protein IL12/FasTI for cancer immune/gene therapy
Yang, Xi
Yu, Xianzhong
Wei, Yanzhang
PLOS ONE, 2018, 13 (07):
[28] Oral Ulcers Resolution Using IL12/23 Blockade in an Infant with Leukocyte Adhesion Deficiency Type 1
Benjamin Fournier
Bénédicte Neven
Stéphanie Chhun
Stéphane Blanche
Martin Biosse Duplan
Journal of Clinical Immunology, 2022, 42 : 907 - 909
[29] Notch inhibitors are a novel, safe, and effective treatment for autoimmune lymphoproliferative syndrome (ALPS)
Teachey, David T.
Seif, Alix
Hall, Junior
Ryan, Theresa
Sheen, Cecelia
Reid, Gregor
Cheng, Yueh
Brown, Valerie I.
Grupp, Stephan A.
PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 633 - 634
[30] Approaches to managing autoimmune cytopenias in novel immunological disorders with genetic underpinnings like autoimmune lymphoproliferative syndrome
Rao, V. Koneti
FRONTIERS IN PEDIATRICS, 2015, 3

← 1 2 3 4 5 →